It was previously shown in neurons derived from FMR1-KO mice and FXS patients that FMRP binds the BMP type II receptor (BMPR2) and regulates its downstream targets, leading to abnormal synaptogenesis [37]. The gene discussed is BMPR2; the disease is fragile X syndrome.